A review of compulsive buying disorder

World Psychiatry. 2007 Feb; 6(1): 14–18.


Compulsive buying disorder (CBD) is characterized by excessive shopping
cognitions and buying behavior that leads to distress or impairment. Found
worldwide, the disorder has a lifetime prevalence of 5.8% in the US general
population. Most subjects studied clinically are women (~80%), though this
gender difference may be artifactual. Subjects with CBD report a preoccupation
with shopping, prepurchase tension or anxiety, and a sense of relief following
the purchase. CBD is associated with significant psychiatric comorbidity,
particularly mood and anxiety disorders, substance use disorders, eating disorders,
and other disorders of impulse control. The majority of persons with CBD appear
to meet criteria for an Axis II disorder, although there is no special “shopping”
personality. Compulsive shopping tends to run in families, and these families
are filled with mood and substance use disorders. There are no standard treatments.
Psychopharmacologic treatment studies are being actively pursued, and group
cognitive-behavioral models have been developed and are promising. Debtors
Anonymous, simplicity circles, bibliotherapy, financial counseling, and marital
therapy may also play a role in the management of CBD.

Keywords: Compulsive shopping, compulsive buying, impulse control disorders

Compulsive buying disorder (CBD) was first described clinically
in the early 20th century by Bleuler (1)
and Kraepelin (2), both of whom included
CBD in their textbooks. Bleuler writes: “As a last category Kraepelin mentions
the buying maniacs (oniomaniacs) in whom even buying is compulsive and leads
to senseless contraction of debts with continuous delay of payment until a
catastrophe clears the situation a little – a little bit never altogether
because they never admit to their debts” (1).
Bleuler described CBD as an example of a “reactive impulse”, or “impulsive
insanity”, which he grouped alongside kleptomania and pyromania.

CBD attracted little attention throughout the 20th century except among
consumer behaviorists (3-6) and psychoanalysts (7-9). Interest was revived in the early 1990s,
when clinical case series from three independent research groups appeared
The disorder has been described worldwide, with reports coming from the US
Canada (5), England (4), Germany (6), France
(13), and Brazil (14).

The appropriate classification of CBD continues to be debated. Some researchers
have linked CBD to addictive disorders (15),
while others have linked it to obsessive-compulsive disorder (16), and still others to mood disorders (17). While not included in DSM-IV (18), CBD was included in DSM-III-R (19) as an example of an “impulsecontrol disorder not otherwise
specified”. Research criteria have been developed that emphasize its cognitive
and behavioral aspects (10). Some writers
have criticized attempts to categorize CBD as an illness, which they see as
part of a trend to “medicalize” behavioral problems (20). Yet, this approach ignores the reality of CBD, and both
trivializes and stigmatizes attempts to understand or treat the disorder.


Koran et al (21) recently estimated
the point prevalence of CBD to be 5.8% of respondents, based on results from
a random telephone survey of 2,513 adults conducted in the US. Earlier, Faber
and O’Guinn (22) had estimated the
prevalence of CBD to fall between 2% and 8% of the general population of Illinois.
Both research groups had used the Compulsive Buying Scale (CBS) (23) to identify compulsive buyers. Other surveys have reported
figures ranging from 12% to 16% (24,25). There is no evidence that CBD has increased
in prevalence in the past few decades.

Community based and clinical surveys suggest that 80% to 95% of persons
with CBD are women (10-12,23). The reported
gender difference could be artifactual: women readily acknowledge that they
enjoy shopping, whereas men are more likely to report that they “collect”.
The report of Koran et al (21) suggests
that this may be the case: in their survey, a near equal percentage of men
and women met criteria for CBD (5.5% and 6.0%, respectively). However, Dittmar
(26) concluded from a general population
survey in the United Kingdom, in which 92% of respondents considered compulsive
shoppers were women, that the gender difference is real and is not an artifact
of men being underrepresented in samples.

The age of onset of CBD appears to be in the late teens or early twenties
(11,12,27), though McElroy et al (10) reported a mean age at onset of 30 years. It may be that
the age of onset corresponds with emancipation from the home, and the age
at which people first establish credit accounts.

There are no careful longitudinal studies of CBD, but the majority of subjects
studied by Schlosser et al (12) and
McElroy et al (10) describe their course
as continuous. Aboujaoude et al (28)
suggested that persons with CBD who responded to treatment with citalopram
were likely to remain in remission during one-year follow-up, a finding that
suggests that treatment could alter the natural history of the disorder. The
authors’ personal observation is that subjects with CBD typically report decades
of compulsive shopping behavior at the time of presentation, although it might
be argued that clinical samples are biased in favor of severity.

There is some evidence that CBD runs in families and that within these
families mood, anxiety, and substance use disorders are excessive. McElroy
et al (8) reported that, of 18 individuals
with CBD, 17 had one or more first-degree relatives (FDRs) with major depression,
11 with an alcohol or drug use disorder, and three with an anxiety disorder.
Three had relatives with CBD. Black et al (29)
used the family history method to assess 137 FDRs of 33 persons with CBD.
FDRs were significantly more likely than those in a comparison group to have
depression, alcoholism, a drug use disorder, “any” psychiatric disorder, and
“more than one psychiatric disorder”. CBD was identified in 9.5% of the FDRs
of the CBD probands (CBD was not assessed in the comparison group). In molecular
genetic studies, Devor et al (30) failed
to find an association between two serotonin transporter gene polymorphisms
and CBD, while Comings (31) reported
an association of CBD with the DRD1 receptor gene.


Persons with CBD are preoccupied with shopping and spending, and devote
significant time to these behaviors. While it might be argued that a person
could be a compulsive shopper and not spend, and confine his or her interest
to window shopping, this pattern is uncommon. The author’s personal observation
is that the two aspects – shopping and spending – are intertwined. Persons
with CBD often describe an increasing level of urge or anxiety that can only
lead to a sense of completion when a purchase is made.

The author has been able to identify four distinct phases of CBD: 1) anticipation;
2) preparation; 3) shopping; and 4) spending. In the first phase, the person
with CBD develops thoughts, urges, or preoccupations with either having a
specific item, or with the act of shopping. In the second phase, the person
prepares for shopping and spending. This can include decisions on when and
where to go, on how to dress, and even which credit cards to use. Considerable
research may have taken place about sale items, new fashions, or new shops.
The third phase involves the actual shopping experience, which many individuals
with CBD describe as intensely exciting, and can even lead to a sexual feeling
(12). Finally, the act is completed
with a purchase, often followed by a sense of let down, or disappointment
with oneself (21). In a study of the
antecedents and consequences of CBD, Miltenberger et al (32) reported that negative emotions (e.g., depression, anxiety,
boredom, self-critical thoughts, anger) were the most commonly cited antecedents
to CBD, while euphoria or relief from the negative emotions were the most
common consequence.

Individuals with CBD tend to shop by themselves, although some will shop
with friends who may share their interest in shopping (11,12). In general,
CBD is a private pleasure which could lead to embarrassment if someone not
similarly interested in shopping accompanied them. Shopping may occur in just
about any venue, ranging from high fashion department stores and boutiques
to consignment shops or garage sales. Income has relatively little to do with
the existence of CBD: persons with a low income can still be fully preoccupied
by shopping and spending, although their level of income will lead them to
shop at a consignment shop rather than a department store.

Typical items purchased by persons with CBD include (in descending order)
clothing, shoes, compact discs, jewelry, cosmetics, and household items (11,12,32). Individually, the items purchased by
compulsive shoppers tend not to be particularly expensive, but the author
has observed that many compulsive shoppers buy in quantity resulting in out
of control spending. Anecdotally, patients often report buying a product based
on its attractiveness or because it was a bargain. In the study by Christenson
et al (11), compulsive shoppers reported
spending an average of $110 during a typical shopping episode compared with
$92 reported in the study by Schlosser et al (12).

Although research has not identified gender specific buying patterns, in
the author’s experience men tend to have a greater interest than women in
electronic, automotive, or hardware goods. Like women, they are also interested
in clothing, shoes, and compact discs.

Subjects generally are willing to acknowledge that CBD is problematic.
Schlosser et al (10) reported that
85% of their subjects expressed concern with their CBD-related debts, and
that 74% felt out of control while shopping. In the study by Miltenberger
et al (32), 68% of persons with CBD
reported that it negatively affected their relationships. Christenson et al
(11) reported that nearly all of their
subjects (92%) tried to resist their urges to buy, but were rarely successful.
The subjects indicated that 74% of the time they experienced an urge to buy,
the urge resulted in a purchase.

CBD tends to occur year round, although it may be more problematic during
the Christmas or other important holidays, and around the birthdays of family
members and friends (12). Schlosser
et al (12) found that subjects reported
a range of behaviors regarding the outcome of a purchase, including returning
the item, failing to remove the item from the packaging, selling the item,
or even giving it away.

In a study of 44 subjects with CBD, Black et al (33) reported that greater severity was associated with lower
gross income, less likelihood of having an income above the median, and spending
a lower percentage of income on sale items. Subjects with more severe CBD
were also more likely to have comorbid Axis I or Axis II disorders. These
data suggest that the most severe forms of CBD are found in persons with low
incomes who have little ability to control or to delay their urge to make
impulsive purchases.


Persons with CBD frequently meet criteria for Axis I disorders, particularly
mood disorders (21-100%) (27,34), anxiety disorders (41-80%) (10,12), substance
use disorders (21-46%) (11,29), and eating disorders (8-35%) (10,27). Disorders
of impulse control are also relatively common in these individuals (21-40%)

Schlosser et al (12) found that
nearly 60% of subjects with CBD met criteria for at least one Axis II disorder.
While there was no special “shopping” personality, the most frequently identified
personality disorders were the obsessive-compulsive (22%), avoidant (15%),
and borderline (15%) types. Krueger (7),
a psychoanalyst, described four patients who he observed to have aspects of
narcissistic character pathology.


The etiology of CBD is unknown, though speculation has settled on developmental,
neurobiological, and cultural influences. Psychoanalysts (7-9) have suggested
that early life events, such as sexual abuse, are causative factors. Yet,
no special or unique family constellation or pattern of early life events
has been identified in persons with CBD.

Neurobiological theories have centered on disturbed neurotransmission,
particularly involving the serotonergic, dopaminergic, or opioid systems.
Selective serotonin reuptake inhibitors (SSRIs) have been used to treat CBD
(27,34- 38), in part because investigators have noted
similarities between CBD and obsessive-compulsive disorder, a disorder known
to respond to SSRIs. Dopamine has been theorized to play a role in “reward
dependence”, which has been claimed to foster “behavioral addictions” (e.g.,
CBD, pathological gambling) (39). Case
reports suggesting benefit from the opiate antagonist naltrexone have led
to speculation about the role of opiate receptors (40,41). There is currently no direct evidence
to support the role of these neurotransmitter systems in the etiology of CBD.

Cultural mechanisms have been proposed to recognize the fact that CBD occurs
mainly in developed countries (42).
Elements which appear necessary for the development of CBD include the presence
of a market-based economy, the availability of a wide variety of goods, disposable
income, and significant leisure time. For these reasons, CBD is unlikely to
occur in poorly developed countries, except among the wealthy elite (Imelda
Marcos and her many shoes come to mind).


The goal of assessment is to identify CBD through inquiries regarding the
person’s attitudes and behaviors towards shopping and spending (43). Inquiries might include: “Do you feel overly preoccupied
with shopping and spending?”; “Do you ever feel that your shopping behavior
is excessive, inappropriate or uncontrolled?”; “Have your shopping desires,
urges, fantasies, or behaviors ever been overly time consuming, caused you
to feel upset or guilty, or lead to serious problems in your life such as
financial or legal problems or the loss of a relationship?”.

Clinicians should note past psychiatric treatment, including medications,
hospitalizations, and psychotherapy. A history of physical illness, surgical
procedures, drug allergies, or medical treatment is important to note, because
it may help rule out medical explanations as a cause of the CBD (e.g., neurological
disorders, brain tumors). Bipolar disorder needs to be ruled out as a cause
of the excessive shopping and spending. Typically, the manic patient’s unrestrained
spending corresponds to manic episodes, and is accompanied by euphoric mood,
grandiosity, unrealistic plans, and often a giddy, expansive affect. The pattern
of shopping and spending in the person with CBD lacks the periodicity seen
with bipolar patients, and suggests an ongoing preoccupation.

Normal buying behavior should also be ruled out. In the US and other developed
countries, shopping is a major pastime, particularly for women, and frequent
shopping does not necessarily constitute evidence in support of a diagnosis
of CBD. Normal buying can sometimes take on a compulsive quality, particularly
around special holidays or birthdays. Persons who receive an inheritance or
win a lottery may experience shopping sprees as well.

Several instruments have been developed to either identify CBD or rate
its severity. The CBS (23), already
mentioned, consists of seven items representing specific behaviors, motivations,
and feelings associated with compulsive buying, and reliably distinguishes
normal buyers from those with CBD. Edwards (44)
has developed a useful 13-item scale that assesses important experiences and
feelings about shopping and spending. Monahan et al (45) modified the Yale
Brown Obsessive-Compulsive Scale to create the YBOCS-Shopping Version (YBOCS-SV)
to assess cognitions and behaviors associated with CBD. This 10-item scale
rates time involved, interference, distress, resistance, and degree of control
for both cognitions and behaviors. The instrument is designed to measure severity
of CBD, and change during clinical trials.


There are no evidence-based treatments for CBD. In recent years, treatment
studies of CBD have focused on the use of psychotropic medication (mainly
antidepressants) and cognitive-behavioral therapy (CBT).

Interest in CBT has largely replaced earlier interest in psychodynamic
therapies. Several competing CBT models have been developed, the most successful
involving the use of group treatment (46-49). The first use of group therapy was described
by Damon (46). Subsequent group models
were developed by Burgard and Mitchell (47),
Villarino et al (48), and more recently
by Benson and Gengler (49). Mitchell
et al (50) reported that their group
CBT model produced significant improvement compared to a wait list in a 12-week
pilot study; improvement was maintained during a 6-months follow-up. Benson
(51) has recently developed a comprehensive
self-help program which combines cognitive- behavioral strategies with self-monitoring.
A detailed workbook, a shopping diary, and a CD-ROM are included.

Several self-help books (bibliotherapy) are available (52- 54), and may be
helpful to some persons with CBD. Debtors Anonymous, patterned after Alcoholics
Anonymous, is a voluntary, lay-run group that provides an atmosphere of mutual
support and encouragement for those with substantial debts. Simplicity circles
are available in some US cities; these voluntary groups encourage people to
adopt a simple lifestyle, and to abandon their CBD (55). Many subjects with CBD develop substantial financial
problems, and may benefit from financial counseling (56). The author has seen cases in which a financial conservator
has been appointed to control the patient’s finances, and appears to have
helped. While a conservator controls the person’s spending, this approach
does not reverse his or her preoccupation with shopping and spending. Marriage
(or couples) counseling may be helpful, particularly when CBD in one member
of the dyad has disrupted the relationship (57).

Psychopharmacologic treatment studies have yielded mixed results. An early
case series suggested that antidepressants could curb CBD (58), and an early open-label trial using fluvoxamine showed
benefit (34). Yet, two subsequent randomized
controlled trials found that fluvoxamine did no better than placebo (35,36).
In another open-label trial (28), citalopram
produced substantial improvement. In this particular study, responders to
open-label citalopram were then enrolled in a nine-week randomized placebo
controlled trial (38). Compulsive shopping
symptoms returned in five of eight subjects assigned to placebo compared with
none of the seven who continued taking citalopram. By comparison, escitalopram
showed little effect for CBD in an identically designed discontinuation trial
by the same investigators (39). Grant
(40) and Kim (41) have described cases in which persons with CBD improved
with naltrexone, suggesting that opiate antagonists might play a role in the
treatment of CBD. Interpretation of treatment studies is complicated by the
high placebo response rate associated with CBD (ranging to 64%) (35).

The author has developed a set of recommendations (59). First, pharmacologic treatment trials provide little
guidance, and patients should be informed that they cannot rely on medication.
Further, patients should: a) admit that they have CBD; b) get rid of credit
cards and checkbooks, because they are easy sources of funds that fuel the
disorder; c) shop with a friend or relative; the presence of a person without
CBD will help curb the tendency to overspend; and d) find meaningful ways
to spend one’s leisure time other than shopping.


1. Bleuler E. New York: Macmillan; 1930. Textbook of psychiatry. [Google Scholar]
2. Kraepelin E. 8th ed. Leipzig: Barth; 1915. Psychiatrie. [Google Scholar]
3. O’Guinn TC. Faber RJ. Compulsive buying: a phenomenological exploration. J Consumer Res. 1989;16:147–157. [Google Scholar]
4. Elliott R. Addictive consumption: function and fragmentation in post-modernity. J Consumer Policy. 1994;17:159–179. [Google Scholar]
5. Valence G. D’Astous A. Fortier L. Compulsive buying: concept and measurement. J Consum Policy. 1988;11:419–433. [Google Scholar]
6. Scherhorn G. Reisch LA. Raab G. Addictive buying in West Germany: an empirical study. J Consum Policy. 1990;13:355–387. [Google Scholar]
7. Krueger DW. On compulsive shopping and spending: a psychodynamic inquiry. Am J Psychother. 1988;42:574–584. [PubMed] [Google Scholar]
8. Lawrence L. The psychodynamics of the compulsive female shopper. Am J Psychoanal. 1990;50:67–70. [PubMed] [Google Scholar]
9. Winestine MC. Compulsive shopping as a derivative of childhood seduction. Psychoanal Q. 1985;54:70–72. [PubMed] [Google Scholar]
10. McElroy S., Jr Keck PE., Jr Pope HG, Jr, et al. Compulsive buying: a report of 20 cases. J Clin Psychiatry. 1994;55:242–248. [PubMed] [Google Scholar]
11. Christenson GA. Faber JR. de Zwann M. Compulsive buying: descriptive characteristics and psychiatric
comorbidity. J Clin Psychiatry. 1994;55:5–11. [PubMed] [Google Scholar]
12. Schlosser S. Black DW. Repertinger S, et al. Compulsive buying: demography, phenomenology, and comorbidity
in 46 subjects. Gen Hosp Psychiatry. 1994;16:205–212. [PubMed] [Google Scholar]
13. Lejoyeux M. Tassain V. Solomon J, et al. Study of compulsive buying in depressed patients. J Clin Psychiatry. 1997;58:169–173. [PubMed] [Google Scholar]
14. Bernik MA. Akerman D. Amaral JAMS, et al. Cue exposure in compulsive buying. J Clin Psychiatry. 1996;57:90. [PubMed] [Google Scholar]
15. Krych R. Abnormal consumer behavior: a model of addictive behaviors. Adv Consum Res. 1989;16:745–748. [Google Scholar]
16. Hollander E, editor. Obsessive-compulsive related disorders. Washington: American Psychiatric Press; 1993. [Google Scholar]
17. Lejoyeux M. Andes J. Tassian V, et al. Phenomenology and psychopathology of uncontrolled buying. Am J Psychiatry. 1996;152:1524–9. [PubMed] [Google Scholar]
18. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed, revised. Washington: American Psychiatric Press; 1987. [Google Scholar]
19. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed, text revision. Washington: American Psychiatric Press; 2004. [Google Scholar]
20. Lee S. Mysyk A. The medicalization of compulsive buying. Soc Sci Med. 2004;58:1709–1718. [PubMed] [Google Scholar]
21. Koran LM. Faber RJ. Aboujaoude E, et al. Estimated prevalence of compulsive buying in the United States. Am J Psychiatry. 2006;163:1806–1812. [PubMed] [Google Scholar]
22. Faber RJ. O’Guinn TC. Classifying compulsive consumers: advances in the development
of a diagnostic tool. Adv Consum Res. 1989;16:147–157. [Google Scholar]
23. Faber RJ. O’Guinn TC. A clinical screener for compulsive buying. J Consumer Res. 1992;19:459–469. [Google Scholar]
24. Magee A. Compulsive buying tendency as a predictor of attitudes and
perceptions. Adv Consum Res. 1994;21:590–594. [Google Scholar]
25. Hassay DN. Smith CL. Compulsive buying: an examination of consumption motive. Psychol Marketing. 1996;13:741–752. [Google Scholar]
26. Dittmar H. Understanding and diagnosing compulsive buying. In: Coombs R, editor. Addictive disorders: a practical handbook. New York: Wiley; 2004. pp. 411–450. [Google Scholar]
27. Koran LM. Bullock KD. Hartston HJ, et al. Citalopram treatment of compulsive shopping: an open-label
study. J Clin Psychiatry. 2002;63:704–708. [PubMed] [Google Scholar]
28. Aboujaoude E. Gamel N. Koran LM. A 1-year naturalistic following of patients with compulsive
shopping disorder. J Clin Psychiatry. 2003;64:946–950. [PubMed] [Google Scholar]
29. Black DW. Repertinger S. Gaffney GR, et al. Family history and psychiatric comorbidity in persons with
compulsive buying: preliminary findings. Am J Psychiatry. 1998;155:960–963. [PubMed] [Google Scholar]
30. Devor EJ. Magee HJ. Dill-Devor RM, et al. Serotonin transporter gene (5-HTT) polymorphisms and compulsive
buying. Am J Med Genet. 1999;88:123–125. [PubMed] [Google Scholar]
31. Comings DE. The molecular genetics of pathological gambling. CNS Spectrums. 1998;6:20–37. [Google Scholar]
32. Miltenberger RG. Redlin J. Crosby R, et al. Direct and retrospective assessment of factors contributing
to compulsive buying. J Behav Ther Exp Psychiatry. 2003;34:1–9. [PubMed] [Google Scholar]
33. Black DW. Monahan P. Schlosser S, et al. Compulsive buying severity: an analysis of compulsive buying
scale results in 44 subjects. J Nerv Ment Dis. 2001;189:123–127. [PubMed] [Google Scholar]
34. Black DW. Monahan P. Gabel J. Fluvoxamine in the treatment of compulsive buying. J Clin Psychiatry. 1997;58:159–163. [PubMed] [Google Scholar]
35. Black DW. Gabel J. Hansen J, et al. A double-blind comparison of fluvoxamine versus placebo in
the treatment of compulsive buying disorder. Ann Clin Psychiatry. 2000;12:205–211. [PubMed] [Google Scholar]
36. Ninan PT. McElroy SL. Kane CP, et al. Placebo-controlled study of fluvoxamine in the treatment of
patients with compulsive buying. J Clin Psychopharmacol. 2000;20:362–366. [PubMed] [Google Scholar]
37. Koran LM. Chuang HW. Bullock KD, et al. Citalopram for compulsive shopping disorder: an open-label
study followed by a double- blind discontinuation. J Clin Psychiatry. 2003;64:793–798. [PubMed] [Google Scholar]
38. Koran LM. Escitalopram treatment evaluated in patients with compulsive
shopping disorder. Primary Psychiatry. 2005;12:13. [Google Scholar]
39. Holden C. Behavioral addictions; do they exist? Science. 2001;294:980–982. [PubMed] [Google Scholar]
40. Grant JE. Three cases of compulsive buying treated with naltrexone. Int J Psychiatry Clin Pract. 2003;7:223–225. [Google Scholar]
41. Kim SW. Opioid antagonists in the treatment of impulse-control disorders. J Clin Psychiatry. 1998;59:159–164. [PubMed] [Google Scholar]
42. Black DW. Compulsive buying disorder: definition, assessment, epidemiology
and clinical management. CNS Drugs. 2001;15:17–27. [PubMed] [Google Scholar]
43. Black DW. Assessment of compulsive buying. In: Benson A, editor. I shop, therefore I am – compulsive buying and the search for self. New York: Aronson; 2000. pp. 191–216. [Google Scholar]
44. Edwards EA. Development of a new scale to measure compulsive buying behavior. Fin Counsel Plan. 1993;4:67–84. [Google Scholar]
45. Monahan P. Black DW. Gabel J. Reliability and validity of a scale to measure change in persons
with compulsive buying. Psychiatry Res. 1995;64:59–67. [PubMed] [Google Scholar]
46. Damon JE. Los Angeles: Price Stein Sloan; 1988. Shopaholics: serious help for addicted spenders. [Google Scholar]
47. Burgard M. Mitchell JE. Group cognitive-behavioral therapy for buying disorders. In: Benson A, editor. I shop, therefore I am – compulsive buying and the search for self. New York: Aronson; 2000. pp. 367–397. [Google Scholar]
48. Villarino R. Otero-Lopez JL. Casto R. Madrid: Ediciones Piramide; 2001. Adicion a la compra: analysis, evaluaction y
tratamiento. [Google Scholar]
49. Benson A. Gengler M. Treating compulsive buying. In: Coombs R, editor. Addictive disorders: a practical handbook. New York: Wiley; 2004. pp. 451–491. [Google Scholar]
50. Mitchell JE. Burgard M. Faber R, et al. Cognitive behavioral therapy for compulsive buying disorder. Behav Res Ther. 2006;44:1859–1865. [PubMed] [Google Scholar]
52. Arenson G. Blue Ridge Summit: Tab Books; 1991. Born to spend: how to overcome compulsive spending. [Google Scholar]
53. Catalano EM. Sonenberg N. Oakland: New Harbinger Publications; 1993. Consuming passions – help for compulsive shoppers. [Google Scholar]
54. Wesson C. New York: St. Martin’s Press; 1991. Women who shop too much: overcoming the urge to splurge. [Google Scholar]
55. Andrews C. Simplicity circles and the compulsive shopper. In: Benson A, editor. I shop, therefore I am – compulsive buying and the search for self. New York: Aronson; 2000. pp. 484–496. [Google Scholar]
56. McCall K. Financial recovery counseling. In: Benson A, editor. I shop, therefore I am – compulsive buying and the search for self. New York: Aronson; 2000. pp. 457–483. [Google Scholar]
57. Mellan O. Overcoming overspending in couples. In: Benson A, editor. I shop, therefore I am – compulsive buying and the search for self. New York: Aronson; 2000. pp. 341–366. [Google Scholar]
58. McElroy S. Satlin A. Pope HG, et al. Treatment of compulsive shopping with antidepressants: a report
of three cases. Ann Clin Psychiatry. 1991;3:199–204. [Google Scholar]
59. Kuzma J. Black DW. Compulsive shopping – when spending begins to consume the consumer. Current Psychiatry. 2006;7:27–40. [Google Scholar]

Articles from World Psychiatry are provided here courtesy of The World Psychiatric Association

Source Article